2021
DOI: 10.1007/s10900-021-00968-3
|View full text |Cite
|
Sign up to set email alerts
|

Correlates of HPV Vaccination Intentions Among Adults Ages 27–45 Years Old in the U.S.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
26
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 16 publications
(28 citation statements)
references
References 19 publications
2
26
0
Order By: Relevance
“…With the coefficient value β=0.394 and T-value 3.873 with p-value=0.000, the bootstrapping results on the SmartPLS 3.0 application prove that the proposed H 2 is accepted and confirmed. The direction of the results of this study is certainly in line with previous supported empirical studies [31]- [36]. The consequence of the desire, will, and intention to be vaccinated is that people perceive that the COVID-19 vaccine provides benefits to them.…”
supporting
confidence: 86%
See 1 more Smart Citation
“…With the coefficient value β=0.394 and T-value 3.873 with p-value=0.000, the bootstrapping results on the SmartPLS 3.0 application prove that the proposed H 2 is accepted and confirmed. The direction of the results of this study is certainly in line with previous supported empirical studies [31]- [36]. The consequence of the desire, will, and intention to be vaccinated is that people perceive that the COVID-19 vaccine provides benefits to them.…”
supporting
confidence: 86%
“…Besides perceived risk, previous researches have also confirmed in their findings that perceived benefits [31]- [36] and perceived susceptibility [37], [38] could also shape vaccination intention and decision with the predictive power of each determinant varies across each study [39]. In addition, a large number of previous studies had focused on the acceptance and adoption of influenza [15], [40], A/H1N1 [41], HPV [42]- [44], Zika Virus (ZikV) [45], and hepatitis vaccines [46].…”
Section: Introductionmentioning
confidence: 82%
“…Although provider recommendation is a key determinant of HPV vaccine uptake (Alber et al, 2021;Reiter, Bustamante, & McRee, 2020), the ACIP guidelines indicate providers do not need to routinely discuss HPV vaccination with 27-to 45-year-old patients (Meites et al, 2019). Hence, patients bear the primary responsibility for initiating shared clinical decision-making (Thompson et al, 2021). Understanding underlying knowledge, attitudes, and beliefs (KABs) about HPV and HPV vaccination among 27-to 45-yearolds can help to facilitate shared clinical decision-making conversations and inform vaccine promotion interventions.…”
mentioning
confidence: 99%
“…Within the appraisal domain of health literacy, perceived vulnerability to cancer was a significant correlate to HPV vaccination with a provider recommendation. A previous study found that adults 27–45 who perceived a benefit from HPV vaccination would be more likely to ask their healthcare provider about the vaccine [ 4 ]. As such, these two findings may highlight an underlying phenomenon that persons who perceived they are vulnerable to cancer may characterize this risk as a potential benefit if vaccinated.…”
Section: Discussionmentioning
confidence: 99%
“…To translate this new HPV vaccine guideline into practice, we need to understand what contributes to HPV vaccination decisions in this age group. Preliminary research has shown that adults ages 27–45 years old are more likely to ask their provider about the vaccine or be likely to receive the HPV vaccine if they perceive a benefit to vaccination [ 4 ]. Thus, a key factor may be provider recommendation, as provider recommendation has been a key facilitator for HPV vaccination for other age groups [ 5 ].…”
Section: Introductionmentioning
confidence: 99%